Chris Cotton is raising money for cancer centers after being told the day after his 50th birthday that what he thought was a ...

Panelists discuss how newer urinary tract infection (UTI) therapies such as pivmecillinam, sulopenem etzadroxil/probenecid, and gepotidacin demonstrate significantly lower resistance rates (below 5%) ...

Urinary tract infections (UTIs) are the most common infectious problem among older adults both in the community and institutional settings. With the expected increase in this population ...

Urinary tract infections (UTIs) are a common burden in patients with diabetes mellitus. Cystitis, ascending infections leading to pyelonephritis, emphysematous complications and renal and ...

Treatment involves antibiotics, which can last between 7 and 14 days. It's crucial to complete the treatment even if symptoms ...

In the 2020-21 period, £145.8m was spent on catheters and catheter maintenance, while £37m was spent on antibiotics for urinary tract infections (Bladder Interest Group, 2021). The hospital’s tissue ...

Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to ...

Having sex is a common cause of urinary tract infections (UTIs), especially for women. Preventative steps like peeing after sex and drinking lots of water may help. A urinary tract infection (UTI ...

UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

In a clinical trial, the UTI drug gepotidacin cleared infections in 93% of cases, performing just as well as the current ...

Biofilms are found in numerous difficult-to-treat infections such as chronic wounds, urinary tract infections, cystic fibrosis-related lung infections, and even acne. The team are now working to ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.